Advanced Technology Corporation

Liege 20 trials 4 recruiting

20 Registered trials

4 Currently recruiting

Organisation

Advanced Technology Corporation

Location

Liege, Belgium

Identifier

ORG-100042501

Address

Avenue Hippocrate 15, 4000, Belgium

Departments

Advanced Technology Corporation
ATC
Clinical Pharmacology Uni
Clinical Pharmacology Unit
Clinical Pharmacology Unit/A.T.C.
CPU
Inokura
Private Research
Pulmonology

Clinical trials at this site (20)

Search interface

First administration in healthy volunteers of a single and increasing dose of a new molecule for the treatment of brain diseases Not authorised

2023-505030-99-00 Post-Traumatic Stress Disorder (PTSD) 1
A Study to Learn About the Study Medicine Called Sigvotatug Vedotin in People with Locally Advanced, Unresectable, or Metastatic Non-Small C… Recruiting

2024-517968-36-00 non-small cell lung cancer 5 2025-07-08
A first-in-human, randomized, double-blind, placebo-controlled, three-part study assessing the safety, tolerability, pharmacokinetics and ph… Recruiting

2025-521556-35-00 Narcolepsy 1 2025-10-28
A clinical study of the V540C vaccine in healthy adults (V540C-003) Recruiting

2024-518863-36-00 Human Papilloma virus 1 2025-05-27
Randomized, double-blind, placebo-controlled, two-part study assessing the safety, tolerability and pharmacokinetics of BP1.7881 administere… Recruiting

2024-512722-28-00 Eosinophilic esophagitis 3 2025-04-22
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) ( MOVE-Lp(a) ) Ended

2025-521067-13-00 Atherosclerotic Cardiovascular Disease (ASCVD) 5 2026-04-24
A clinical study of MK-6916 in healthy people (MK-6916-006) Ended

2025-521487-36-00 Acute and chronic Pain 3 2025-06-02
Open label, single-center, cross-over randomized, relative bioavailability study comparing a new pitolisant hydrochloride tablet formulatio… Ended

2025-520980-41-00 narcolepsy with cataplexy 3 2025-04-08
A clinical study of the V540A vaccine in healthy adults (V540A-001) Ended

2024-515785-14-00 Human Papilloma virus 1 2024-10-22
Open label, single-center, cross-over randomized, relative bioavailability study comparing a new pitolisant hydrochloride tablet formulation… Ended

2024-513383-26-00 Narcolepsy 3 2024-10-01
Open label, single-center, two-part pharmacokinetic study: Part I: Relative bioavailability study to compare the pharmacokinetics of BP1.497… Ended

2024-512355-20-00 Binge eating disorder 3 2024-08-01
MK-8507 Extended Multiple Dose Study Ended

2023-506697-12-00 HIV-1 infection 3 2023-10-20
Open label, single-center, four-part registration pharmacokinetic study: Part I: Pilot 2-way cross-over randomized, comparative pharmacokine… Ended

2023-507316-12-00 Narcolepsy with cataplexy 3 2023-10-20
MK-3508 Multiple Ascending Dose Study in Healthy Participants Ended

2023-505821-15-00 Respiratory syncytial virus infection 3 2023-10-12
A study to investigate the effects of multiple doses of obefazimod on a combined oral contraceptive (ethinyl estradiol/drospirenone) in hea… Ended

2023-505297-15-00 Healthy female participants of childbearing potential. 3 2023-10-10
Open label, single-center, cross-over randomized, relative bioavailability study comparing 4 new BF2.649 (pitolisant) tablet formulations ve… Ended

2023-505769-98-00 Narcolepsy 3 2023-09-26
A clinical study of MK-6552 in healthy adults (MK-6552-002) Ended

2023-504954-37-00 Narcolepsy 3 2023-07-07
Randomized, double-blind, placebo-controlled study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of pitolisant a… Ended

2023-503945-78-00 Narcolepsy with cataplexy 3 2023-06-13
A Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of MK-3508 in Healthy Participants Ended

2022-502926-42-00 Respiratory syncytial virus infection 1 2023-03-30
A Multiple-Dose Clinical Study to Evaluate Safety, Tolerability, and Pharmacokinetics of MK-8527 in Healthy Participants Expired

2022-502081-24-00 HIV-1 (Human Immunodeficiency Virus Type 1) 3